Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06BWZ
|
||||
| Former ID |
DNC012110
|
||||
| Drug Name |
MEZILAMINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533406] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H18ClN5S
|
||||
| Canonical SMILES |
CNC1=NC(=C(C(=N1)Cl)SC)N2CCN(CC2)C
|
||||
| InChI |
1S/C11H18ClN5S/c1-13-11-14-9(12)8(18-3)10(15-11)17-6-4-16(2)5-7-17/h4-7H2,1-3H3,(H,13,14,15)
|
||||
| InChIKey |
ITYXRJDDBZMFAY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [533406] | |
| Alpha-2A adrenergic receptor | Target Info | Inhibitor | [533406] | ||
| Alpha-2B adrenergic receptor | Target Info | Inhibitor | [533406] | ||
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.